RBC Capital on Legend Biotech Corp. (LEGN): 'We remain buyers' Jun 1, 2026 07:48AM
Legend Biotech Corp. (LEGN) PT Raised to $64; RBC Capital: 'We see opportunity for share appreciation' May 13, 2026 08:50AM
RBC on Legend Biotech Corp. (LEGN): 'We Think Shares Remain Undervalued' Apr 20, 2026 10:51AM
Legend Biotech Corp. (LEGN) PT Lowered to $62 at RBC Capital; 'Shares Should Rebound in 2026' Mar 11, 2026 08:46AM
RBC Capital Defends Legend (LEGN) For Second Day in a Row As Stock Continues to Push Lower Dec 9, 2025 12:38PM


Dec 8, 2025 07:49AM RBC Capital on Legend Biotech Corp. (LEGN): 'We Would Be Buyers'
Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview
Sep 12, 2025 06:29AM RBC Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
Aug 12, 2025 10:20AM Legend Biotech Corp. (LEGN) PT Raised to $77 at RBC Capital on Growth Potential
Jun 2, 2025 07:03AM RBC Capital: 'Legend Biotech Corp. (LEGN) Still Undervalued'
May 16, 2025 10:32AM RBC Capital on Legend Biotech Corp. (LEGN): 'We See A Compelling Valuation'
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Mar 12, 2025 10:56AM RBC Capital on Legend Biotech Corp. (LEGN): 'See An Attractive Entrypoint With Strong 2025 Growth Potential'
Dec 16, 2024 07:03AM RBC Capital's Global Biotech Outlook Report: 'Top 2025 Ideas'
Jun 21, 2024 05:53AM RBC Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
May 14, 2024 06:11AM Legend Biotech Corp. (LEGN) PT Raised to $86 at RBC Capital
May 11, 2023 04:01PM Legend Biotech Announces Participation in Upcoming Investor Conference